TLIS

Talis Biomedical Corporation TLIS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TLIS PLLWF TBRIF RQHTF LLBO NRPR HAVLF SYDRF NUMD BNVIF
6M 98.60 % -90.91 % -43.06 % 400.00 % 700.00 % 123.81 % 280.00 % 25.00 % -63.16 % 0.00 %
YTD 67.06 % -93.33 % -80.21 % 733.33 % 700.00 % 193.75 % 90.00 % 150.00 % 20.00 % 900.00 %
1Y 67.06 % -93.33 % -75.60 % 1 011.11 % 700.00 % 193.75 % -63.46 % 150.00 % 5.26 % 9 900.00 %
3Y -59.31 % -99.84 % -88.35 % -97.32 % 166.67 % 38.24 % -95.00 % -33.33 % -9.26 % -56.33 %
5Y -99.32 % -99.74 % -97.09 % -97.00 % 60.00 % 561.97 % -99.99 % -35.53 % -97.70 % -99.24 %
10Y -99.32 % -99.58 % -79.98 % -93.29 % -68.00 % 623.08 % -99.99 % -35.53 % -98.04 % -99.94 %
From the beginning -99.32 % -99.58 % -79.98 % -96.82 % -100.00 % -99.92 % -99.99 % -35.53 % -97.54 % -99.94 %

Dividend